Endometrial regeneration is essential for normal endometrial function; however, it is unclear whether and how menstrual blood-derived stem cells (MenSCs) and platelet-derived growth factor (PGDF) are associated with this phenomenon. The present study explored this topic.
Background
Remodeling of the human uterus naturally occurs throughout menstruation and parturition [1] . During the remodeling period, the endometrium tissue undergoes a repeated process involving proliferation, differentiation, shedding, and repair in response to estrogen and progesterone [2] . Normal involution returns the uterus to the physiological homeostasis for the new menstrual cycle or for an optimal environment receptive to a new conceptus [3] . Although the endometrium has a strong regenerative ability, intrauterine surgery or infection can easily cause a poor or thin endometrium, leading to amenorrhea, infertility, and uterine adhesion [4] [5] [6] . Recent progress has been made in uterine or endometrial reconstruction in animal models with endometrial injury [7] , but few methods are available to effectively restore the damaged uterus to normal structure and function.
The endometrium consists of columnar epithelium, stroma, and microvessel [7] [8] [9] . Remarkably, luminal epithelium is shed and microvessels are damaged at the site of disrupted endometrium [10] . Epithelial renewal or re-epithelialization has been described to be mediated by migration and proliferation of residual epithelial cells in the remaining basal layer, and by differentiation of endometrial stem/progenitor cells [10] [11] [12] [13] . Re-epithelialization and re-vascularization of the denuded uterine surface are critical factors contributing to successful repair and remodeling of the endometrium [10, 11, 14] . However, this normal process is disrupted or hampered by clinically severe endometrial injury.
Endometrial stem cells (EnSCs) are identified in both the functional and basal layer of regenerative human endometrium [15, 16] , which can be used for the reconstruction of the human uterus and other organs [17, 18] . They can be easily obtained from menstrual blood shedding without invasive surgical intervention or hospitalization, and the isolation is free of ethical concerns [12, 19] . Furthermore, MenSCs demonstrate improved proliferation and differentiation potency [12, 20] . Considering these advantages, MenSCs would be a good choice for use in cell-based therapy for tissue repair or regeneration. The regenerative potential of MenSCs has been demonstrated in preclinical studies of central nerve disorders [20] , heart failure [21] , limb ischemia [22] , and endometrial injury [14] . However, the effect of MenSCs on endometrial epithelium has not been explored.
The platelet-derived growth factor (PDGF) family consists of 4 homodimeric proteins (PDGF-AA, PDGF-BB, PDGF-CC, and PDGF-DD) and 1 heterodimeric protein (PDGF-AB) [23, 24] . PDGF-mediated signaling plays an essential role in cellular proliferation, migration, angiogenesis, and tissue injury and in its repair [25] . Distinct PDGF isoforms, especially PDGF-BB, have been shown to stimulate proliferation and migration of endometrial stromal cells in vitro, indicating that PDGF can help promote endometrial tissue repair [23, 26] . The effect of PDGF on endometrial epithelial cells has not been reported. It was recently reported that platelet-derived soluble factors can promote migration and proliferation of endometrial epithelial cells in vitro [10] . Therefore, we speculated that PDGF can exert a similar effect on re-epithelialization of endometrial epithelial cells.
This study aimed to evaluate the effect of MenSCs, PDGF-BB, and their combination on the regeneration of endometrial epithelium in vitro and in vivo and to elucidate the underlying mechanisms. Our findings may provide a novel therapeutic strategy for endometrial injury.
Material and Methods

Cell culture and treatment
The human endometrial epithelial cell line EM-E6/E7/hTERT was immortalized by the expression of HPV16 E6/E7 and telomerase reverse transcriptase (TERT). Stably established EM-E6/E7/hTERT cells were cultured in DMEM/F12 supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich, USA), 100 U/mL penicillin G sodium, 100 μg/mL streptomycin sulfate, and 25 μg/mL insulin-transferrin-selenium (Invitrogen, USA). MenSCs were purchased from Cryo-Cell International, Inc. (Oldsmar, USA) and maintained in DMEM containing 10% FBS and 1% (v/v) penicillin and streptomycin. All the cells were kept in a 37°C incubator with 5% CO 2 . Cells were passaged when reaching 80-90% confluence, and cells in logarithmic growth phase were used for further experiments. Human umbilical vein endothelial cells (HUVECs) have the potential of stem cells, so they are often selected for angiogenesis experiments. HUVECs were purchased from ATCC (Manassas, VA, USA). HUVECs was cultured in DMEM medium (1X, Gibco, Invitrogen, USA) containing 4.5 g/L D-Glucose, L-Glutamine, and 110 mg/L sodium pyruvate and placed in a 37°C, 5% CO 2 incubator. Cells in logarithmic growth phase were selected for experimentation after the cells grew to 80% confluence, and the cells were collected for detection. EM-E6/E7/hTERT cells were divided into 5 groups: no treatment (control group), phosphate-buffered saline (PBS) treatment (negative control group, NC group), PDGF (5 μg/mL) treatment (PDGF group), MenSCs (10 cells/mL) co-culture (MenSCs group), and the combined MenSCs and PDGF treatment (MenSCs + PDGF group).
Proliferation assay
Cell proliferation was measured using CCK-8 assay (Bio-Rad, USA). Cells (2×10 4 ) were cultured for 24, 48, 72, and 96 h.
We added 10 μL of CCK-8 solution (DojinDo, Shanghai, China) to each well. After incubation for 4 h at 37°C, the medium was discarded and the cells were incubated with 150 μL of DMSAO (Bio-Rad, USA). The plate was shaken on a micro-vibrator for 10 min, and the optical density (OD) of each well was measured using an ELISA reader (Bio-Rad, USA) at 490 nm.
Transwell assay
Cell invasion and migration were assessed by Transwell assay performed using 24-well Transwell filters (8 μm pores, BD Biosciences, USA). Briefly, a mixture of 50 μL Matrigel was added to the upper chamber and cured in a 37°C incubator for 30 min. A total of 5×10 4 cells were added to the upper chamber in serum-free media, while the lower chamber was filled with DMEM containing 20% FBS. After 24-h incubation, the cells that penetrated into the lower chamber were fixed and stained with 0.5% crystal violet for 20 min.
Tube formation assay
Fifty microliters of Matrigel (BD Bioscience, USA) was plated into 96-well plates at a horizontal level and allowed to polymerize at 37°C for 1 h. HUVECs cells were digested, centrifuged at 1000 rpm for 5 min, and resuspended. The cell suspension was seeded on the top of the polymerized Matrigel layer at a density of 4×10 4 cells/well. The cells were treated with either MenSCs, PDGF, or the combination. Following incubation at 37°C for 48 h, tube formation was assessed.
Experimental animals and ethics statement
We purchased 150 female ICR mice, weighing 18-22 g, from Jinan Pengyu Experimental Animal Breeding Co. (Shandong, China, License Number: SCXK (Lu) 2014007). The mice were kept in a well-ventilated and quiet animal house at our hospital for 1 week of acclimation prior to the experiments. The room temperature was 22-24°C and the relative humidity was 50-60%. The mice were given free access to food and water during the entire experimental period.
All experiments were conducted in conformity with NIH guidelines (NIH Pub. No. 85-23, revised 1996) and all protocols were approved by the Animal Care and Use Committee of our hospital.
Animal models and experiments
After intraperitoneal injection of 0.6% sodium pentobarbital (40 mg/kg), the mice were anesthetized and placed on a 37°C thermostatically controlled heated pad. The cortex was lifted with ophthalmic forceps at about 0.5 cm above the urethral orifice and cut layer-by-layer with ophthalmic scissor to expose the Y-shaped uterus behind the bladder. The right uterine horn was gently picked out. Then, the second venous indwelling needle was inserted from the vagina of the uterine cavity and out of the ovary to connect with a catheter connected to a water source at 85°C, while the other end was connected to a 50-mL syringe. Then, the hot water was pumped out at a relatively slow and uniform speed. The hot water passed through the indwelling needle for 80 s. After that, the indwelling needle tube was taken out. The uterus and intestinal tube were reset, and the abdomen was washed with 20000 U/mL penicillin. The skin was sterilized, and the abdomen was closed by sutures layer-by-layer.
Mice were randomly divided into 5 groups: Model group, NC group (an intraperitoneal injection of 100 μL PBS), MenSCs group (an intrauterine injection of 1 × 10 3 cells in 100 μL PBS), PDGF group (an intraperitoneal injection of 500 ng PDGF in 100 μL PBS), and MenSCs+PDGF group (the combined injection of MenSCs and PDGF). Six mice in each group were sacrificed on the 0 th , 5 th , 10 th , 15 th day after injection, respectively, for Western blot assay. The remaining mice were sacrificed at 8 weeks and the uteruses were taken surgically for H&E staining and immunohistochemistry assays.
Histology and immunohistochemistry
The mouse uterus was removed surgically and fixed in 4% paraformaldehyde. The samples were embedded in paraffin and cut into 4-μm sections. The paraffin sections were dewaxed with xylene, dehydrated with serial dilutions of ethanol, and stained with hematoxylin and eosin (H&E) (Solelab, China). CD34 expression was analyzed using immunohistochemistry assay. The sections were incubated with rabbit anti-CD34 monoclonal antibody (1: 100, Abcam, UK) overnight at 4°C. The sections were washed and incubated with an HRP-conjugated goat anti-rabbit IgG secondary antibody (1: 1000, Abcam, UK) for 40 min at room temperature. The cells were visualized using diaminobenzidine (DAB) substrate (Maixin Biotech, China) and counterstained with hematoxylin (Beyotime Biotechnology, China) for 3 min.
Western blot
Total protein was separated in 10% sodium dodecylsulfate polyacrylamide gels (SDS-PAGE) and then transferred to polyvinylidene difluoride (PVDF) membranes (Merck, Darmstadt, Germany). The membranes were blocked in Tris-buffered saline Tween 20 (TBST) solution containing 5% skim milk at room temperature for 2 h, and then probed overnight with primary antibodies at 4°C. The following antibodies were used: Rabbit anti-Akt antibody 
Statistical analysis
All data were analyzed using SPSS 19.0 software. The values are presented as mean±standard deviation (SD) from at least 3 independent experiments. One-way ANOVA (analysis of variance) was used for comparison of multiple groups, followed by LSD test for subsequent analysis. P values below 0.05 were regarded as indicating statistically significant differences.
Results
Effect of MenSCs and PDGF on EM-E6/E7/hTERT cell proliferation
EM-E6/E7/hTERT cells were subjected to different treatments, and cell proliferation was determined by CCK-8 assay. As shown in Figure 1 , PDGF or MenSCs treatment resulted in significant promotion of cell proliferation in a time-dependent manner compared to the untreated control and NC groups (p<0.05). The combined treatment with PDGF and MenSCs enhanced the cell proliferation to a greater extent than in either the PDGF or MenSCs group (p<0.05). These results indicated a synergistic pro-proliferative effect of the combination of PDGF and MenSCs.
Effect of PDGF and MenSCs on EM-E6/E7/hTERT cells migration and invasion
To evaluate the effect of PDGF and MenSCs on cell migration and invasion, Transwell assay was used ( Figure 2 ). The PDGF+MenSCs group presented a higher invasive potential, compared with the NC or control group (p<0.05). Compared with the PDGF or MenSCs group, the PDGF+MenSCs group also showed a significant increase in migration and invasion (p<0.05). Our data suggest that PDGF and MenSCs markedly enhance the ability of endometrial epithelial cells to migrate in vitro in a synergistic fashion.
Effect of PDGF and MenSCs on tube formation in vitro
We examined whether PDGF and MenSCs could regulate the differentiation of endometrial endothelial cells into tube-like structures using HUVECs cells plated on a Matrigel matrix. As shown in Figure 3 , cells formed tube-like structures when cultured alone on Matrigel in the control or NC group; however, the addition of PDGF or MenSCs led to a significant increase in the number of tube-like structures at similar level as in the control or NC group (p<0.05). We next assessed whether PDGF and MenSCs play a synergistic role of tube formation. We found that the combination treatment with PDGF and MenSCs significantly enhanced the number of tube-like structures relative to PDGF or MenSCs treatment alone (p<0.05).
Effect of PDGF and MenSCs endometrial morphology
Histopathologically, endometrial tissues in the NC group were clearly stratified and showed normal architecture ( Figure 4A ). Obvious histomorphological changes were observed in the endometrial lesions of the model group, which simultaneously included mononuclear cellular infiltration, numerous dilated and congested blood vessels, and interstitial edema, together with loss of luminal and glandular epithelium ( Figure 4B ). PDGF or MenSCs treatment significantly promoted repair of the damaged endometrial tissues in the animal models, inducing the reappearance of clearly stratified tissue structure and regeneration of stromal cells and epithelial cells ( Figure 4C, 4D) . Similar results were observed in the PDGF+MenSCs group, in which the endometrial tissue regained its normal appearance and structure ( Figure 4E) . Histological results supported a synergistic regenerative effect of a combination of PDGF and MenSCs in the endometrial damage mouse models.
Effect of PDGF and MenSCs on microvessel formation in vivo
CD34 is regarded as the most sensitive marker for detection of microvessels. Accordingly, we examined CD34 expression in the endometrial tissue using IHC analysis. There were significant increases in CD34 expression in the endometrial tissue following treatment with PDGF (p<0.05) or MenSCs (p<0.05) compared with the Model group ( Figure 5 ). Furthermore, the PDGF+MenSCs group showed remarkably higher upregulation of CD34 expression than in the PDGF or MenSCs group alone (p<0.05). Our data indicated that PDGF or MenSCs significantly promoted microvessel formation of the endometrial lesion of the mouse models, and the combination of PDGF and MenSCs exerted a more pronounced effect on tube formation and endometrial repair.
Effect of MenSCs and PDGF on activation of Akt and Bad in endometrial tissue
The expression and phosphorylation of Akt and Bad in the endometrial tissue were assessed by Western blot analysis at different time points (0, 5, 10, 15 days) after surgery ( Figure 6 ). However, the extent of phosphorylation of both Akt and Bad was significantly higher in the PDGF or MenSCs group com- 
Discussion
The present study is the first to provide the evidence that MenSCs and PDGF might be candidate substances for endometrial injury repair through contributing to EM-E6/E7/hTERT cells proliferation, migration, and invasion. Further, the in vivo data confirmed that MenSCs and PDGF can promote vascular formation of endometrial epithelial cells and phosphorylation of Akt and Bad in endometrium.
Adult stem cells have proven to be an attractive cell type for tissue repair therapeutics due to their remarkable regenerative capacity. Studies have shown that stem cells can also migrate to the injured site, where they promote cell migration, proliferation, and differentiation and play critical roles in re-epithelialization and tissue repair [27] . To substantiate the possible
